Latest News

New blood test predicts which COVID-19 patients will develop severe infection

18th October 2020      Prof. Gerry McElvaney, Chairman of the Department of Medicine and Vice Dean of the School of Medicine, Royal College of Surgeons in Ireland and Prof. Gerard Curley,   Professor of Anaesthesia and Critical Care at
Read More

Vertex Abandons VX-814 Program for Treating Rare Liver Disease

18th October 2020   Vertex Pharmaceuticals announced that based on early data of its Phase II trial of VX-814 in Alpha-1 antitrypsin deficiency (AATD), it is halting the trial and ending development of the drug. AATD is a genetic disease resulti
Read More

BBC documentary Surgeons: At the edge of life will show AATD patient receive a double lung transplant.

On Tuesday 20 October, the BBC documentary Surgeons: At the edge of life will show David (pictured below) receiving a double lung transplant. David received his new lungs earlier this year at the Royal Papworth Hospital, Cambridge. The show airs on B
Read More

Grifols begins phase 3 testing for COVID-19 treatment

  RESEARCH TRIANGLE PARK — Grifols, a global biotherapeutics company, has begun Phase 3 clinical trials in patients with COVID-19 with its therapeutic manufactured in Clayton. The Spanish company is testing its hyperimmune globulin for its safet
Read More

Can you help name the new Baby Bears?

Exciting news!   Alphie and Tripsy are delighted to welcome a new sister and brother to their Alpha family.  But they now need your help. We need names for our new mini bears.  Just fill out the form on our web site with up to 5 names each for o
Read More

Carriers of two genetic mutations at greater risk for illness and death from COVID-19

Tel Aviv University researchers suggest that carriers of the genetic mutations PiZ and PiS are at high risk for severe illness and even death from COVID-19. These mutations lead to deficiency in the alpha1-antitrypsin protein, which protects lung tis
Read More